Page has articles related to FDA Approval stock market trading terms. Tries to list FDA Approval artilces of interest and provides latest stockmarket news for private investors. mergers-and-acquisitions.php
11/18/2018 07:01 PM
Dr. Deol on the FDA Approval of Eltrombopag in Severe Aplastic Anemia
Abhinav Deol, MD, associate professor, Karmanos Cancer Institute, discusses the expanded FDA approval of eltrombopag (Promacta) in combination with standard immunosuppressive therapy for the treatment of newly diagnosed adult and pediatric patients ...
11/16/2018 10:30 PM
Eltrombopag Gets FDA Approval for Adult, Pediatric Severe Aplastic Anemia
The oral thrombopoietin receptor agonist (TPO-RA) has been previously approved by the FDA for SAA for patients with an insufficient response to IST, for adults and children with chronic immune thrombocytopenia (ITP) who are refractory to other ...
Novartis' blood disorder drug gets FDA approval for expanded use
FDA approves Novartis (NVS) drug Promacta for first-line SAA and grants Breakthrough Therapy designation
11/16/2018 10:14 PM
FDA approves new drug to treat travelers' diarrhea
The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever ...
FDA Approves Rifamycin for Traveler's Diarrhea
11/16/2018 10:10 PM
First-line Treatment for PTCL Granted FDA Approval Under New Review Pilot
According to Richard Pazdur, MD, director of the FDA's Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products, the application also was approved by the FDA through the new Real-Time Oncology Review ...
FDA approves first-line treatment for peripheral T-cell lymphoma under new review pilot
Seattle Genetics stock jumps 6% after new FDA approval for lymphoma treatment
FDA Gives Speedy Approval to Brentuximab for Peripheral T-cell Lymphoma
11/16/2018 07:42 PM
The Hutchinson News
Kansas company receives FDA approval for human trials of cancer treatment
The Hutchinson News
A Sterling company received approval today from the Food and Drug Administration to conduct human clinical trials for its new cancer treatment. Trials could begin early next year for Genzada Pharmaceuticals' cancer-fighting agent made from a lily that ...
11/16/2018 07:02 PM